2009
DOI: 10.1016/j.jpba.2008.10.012
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography–tandem mass spectrometry and its application in a pharmacokinetic study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
18
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(19 citation statements)
references
References 10 publications
1
18
0
Order By: Relevance
“…46,47 This LOQ compares favorably with values obtained via HPLC-UV (12 ng/mL) 48 but is roughly an order of magnitude higher than results reported using HPLC–MS. 49 In addition to an improvement in precision, improvements in enalapril linearity (Supplemental Figure 2) and accuracy (Table 2) were also observed upon normalization to ramipril. As determined in the range of 0.03 to 10 μ M, a least-squares linear regression analysis showed an improvement in the correlation coefficient from R 2 ≈ 0.9966 to R 2 ≈ 0.9998 upon normalization (Supplemental Figure 2).…”
Section: Resultsmentioning
confidence: 90%
“…46,47 This LOQ compares favorably with values obtained via HPLC-UV (12 ng/mL) 48 but is roughly an order of magnitude higher than results reported using HPLC–MS. 49 In addition to an improvement in precision, improvements in enalapril linearity (Supplemental Figure 2) and accuracy (Table 2) were also observed upon normalization to ramipril. As determined in the range of 0.03 to 10 μ M, a least-squares linear regression analysis showed an improvement in the correlation coefficient from R 2 ≈ 0.9966 to R 2 ≈ 0.9998 upon normalization (Supplemental Figure 2).…”
Section: Resultsmentioning
confidence: 90%
“…Compared to other MS approaches, MRM provides higher sensitivity and specificity 28 . MRM assays have been used to study the pharmacokinetics of enalapril, an ACE inhibitor used in the treatment of hypertension and congestive heart failure 51 . The MRM approach was also used to simultaneously quantify seven angiotensin II receptor antagonists in plasma of patients undergoing cardiovascular treatment 52 .…”
Section: How To Develop a Quantitative View Of Proteolytic Processing?mentioning
confidence: 99%
“…So far little of the potential that MRM assays could have in protease research has been realized. Notable exceptions are the utilization of MRM-assays to measure the abundances of vasoactive peptides in plasma in response to the injection of ACE-inhibitors [54] and the absolute quantitation of protease inhibitors in patient samples [55]. …”
Section: Introductionmentioning
confidence: 99%